Pharmacy Bulletin (Special Edition)

Pharmacy Bulletin (Special Edition)

We share important prescription drug information to help you stay informed about updates concerning particular prescription medicines.

VativoRx Bottle update

Aduhelm™ (aducanumab) – New drug approval

On June 7, 2021, the FDA announced the controversial approval of Biogen’s Aduhelm (aducanumab), for the treatment of Alzheimer’s disease.

This information is shared with you from our partners at OptumRx.

If you’d like to receive the weekly bulletin by email, please let us know.